A quantitative and qualitative comparison of illumina MiSeq and 454 amplicon sequencing for genotyping the highly polymorphic major histocompatibility complex (MHC) in a non-model species by Razali, H. et al.
Razali et al. BMC Res Notes  (2017) 10:346 
DOI 10.1186/s13104-017-2654-1
RESEARCH ARTICLE
A quantitative and qualitative 
comparison of illumina MiSeq and 454 
amplicon sequencing for genotyping the highly 
polymorphic major histocompatibility complex 
(MHC) in a non-model species
Haslina Razali1†, Emily O’Connor2*†, Anna Drews2, Terry Burke1 and Helena Westerdahl2
Abstract 
Background: High-throughput sequencing enables high-resolution genotyping of extremely duplicated genes. 
454 amplicon sequencing (454) has become the standard technique for genotyping the major histocompatibility 
complex (MHC) genes in non-model organisms. However, illumina MiSeq amplicon sequencing (MiSeq), which offers 
a much higher read depth, is now superseding 454. The aim of this study was to quantitatively and qualitatively 
evaluate the performance of MiSeq in relation to 454 for genotyping MHC class I alleles using a house sparrow (Passer 
domesticus) dataset with pedigree information. House sparrows provide a good study system for this comparison as 
their MHC class I genes have been studied previously and, consequently, we had prior expectations concerning the 
number of alleles per individual.
Results: We found that 454 and MiSeq performed equally well in genotyping amplicons with low diversity, i.e. ampli-
cons from individuals that had fewer than 6 alleles. Although there was a higher rate of failure in the 454 dataset in 
resolving amplicons with higher diversity (6–9 alleles), the same genotypes were identified by both 454 and MiSeq in 
98% of cases.
Conclusions: We conclude that low diversity amplicons are equally well genotyped using either 454 or MiSeq, 
but the higher coverage afforded by MiSeq can lead to this approach outperforming 454 in amplicons with higher 
diversity.
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Background
The major histocompatibility complex (MHC) plays a 
key role in adaptive immunity by presenting antigens to 
the immune system for elimination [1]. Across all known 
vertebrates, the genetic region encoding the MHC is 
the most polymorphic described to date [2]. This poly-
morphism is thought to be primarily maintained by the 
selective advantage conferred by rare and/or multiple 
MHC alleles in the recognition and elimination of path-
ogens [3–5]. Within the fields of ecology and evolution-
ary biology, MHC genes have attracted a great deal of 
research attention, mostly due to their association with 
fitness-related traits, e.g. survival, lifetime reproductive 
success, disease resistance and fecundity [6–10]. How-
ever, the polymorphic and polygenic nature of MHC 
genes makes accurate genotyping a challenge [11, 12]. 
High-throughput sequencing (HTS) technologies offer 
an excellent opportunity for deep sequencing at a rela-
tively low cost, which makes sequencing all MHC alleles 
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simultaneously in an individual affordable and practi-
cal [13, 14]. Consequently, HTS has become the stand-
ard approach for sequencing MHC genes in non-model 
organisms [e.g. 15–19].
HTS comes at the cost of ‘noisy’ data: the high read 
numbers obtained through HTS are associated with 
a substantial number of artefactual reads [20–23]. An 
enduring challenge when working with HTS data is accu-
rately separating true allelic reads from artefacts. This 
can be particularly difficult when working with a multi-
gene family, such as the MHC, as the MHC region holds 
many similar copies of genes that cannot be amplified 
separately. When there are many similar alleles present 
in an amplicon, it can be difficult to distinguish between 
true allelic variants and artefactual reads based upon 
nucleotide differences and relative read depths, which is 
a central tenet of most genotyping techniques [13, 17, 24, 
25].
Roche 454 amplicon sequencing (454) has been a pop-
ular choice in the study of MHC [e.g. 13, 15, 24]. How-
ever, 454 is being replaced by illumina MiSeq amplicon 
sequencing (MiSeq), which has now been used to accu-
rately genotype MHC genes across many species with 
differing degrees of MHC complexity [17, 25, 26]. The 
MiSeq platform offers greater sequence coverage at a 
lower per-base cost than 454 and generates substantially 
fewer sequencing errors [27]. This lower error-rate could 
be particularly beneficial in study systems where individ-
uals possess a high number of MHC alleles, as is the case 
in many bird species within the order Passeriformes [e.g. 
25, 28–31].
To date, the focal exons in HTS studies of MHC in avian 
non-model organisms have been MHC class I exon 3 and 
MHC class IIB exon 2, as these exons encode regions 
responsible for antigen binding [19, 25, 28, 31–36]. MHC 
genotyping in Passeriformes presents a challenge, but 
also an excellent opportunity to test the level of diversity 
(number of alleles per individual) at which MiSeq outper-
forms 454. Although it has been suggested that MiSeq 
improves our ability to discern true alleles from artefacts 
in species with many MHC genes [25], this has yet to be 
tested directly. This is an important omission as there is 
still a great deal of research being published that has used 
454 for MHC genotyping [31, 35–39]. Thus, it is valuable 
to determine, in species with many MHC gene copies, 
how 454 and MiSeq genotyping compares.
The aim of this study was to evaluate and compare, 
quantitatively and qualitatively, the performance of 454 
and MiSeq for genotyping MHC class I alleles in house 
sparrows (Passer domesticus), as an example of a non-
model species with multiple MHC gene copies. We have 
chosen house sparrows since they have duplicated MHC 
class I genes and several studies have already investigated 
variation in MHC class I exon 3 in this species over the 
last 10 years using different molecular genetic techniques 
[30, 32, 40, 41]. The earlier studies provides a prior expec-
tation of the number of MHC class I alleles per individual 
house sparrow, as well as the expected allelic variation, 
e.g. allele length differences. Our dataset comprises both 
MiSeq and 454 data from the same 11 house sparrow 
families (81 individuals), plus 15% replicated samples. 
We have prior knowledge of primer performance, as well 
as the advantage of being able to use heritability within 
families to aid our assessment of the performance of the 
different techniques of MHC genotyping [30, 42]. It is 
important to bridge the gap between former and present 
molecular genetic methods, such as 454 and MiSeq, in 
order to be able to evaluate and interpret data from dif-
ferent ‘methodological eras’.
Methods
Samples and molecular methods
Blood samples were taken from 81 house sparrow indi-
viduals comprising 11 families: 11 adult males, 10 adult 
females and 60 nestlings (with nestlings often being 
combined from successive broods belonging to the same 
breeding pair). There was a minimum of three offspring 
in each family. The sparrow samples were obtained from 
a population inhabiting Lundy Island, located in the Bris-
tol Channel (51°10°N, 4°40°W, UK) [43].
Genomic deoxyribonucleic acid (DNA) was extracted 
using a salt extraction [44]. The DNA concentration was 
then standardized to 20–25  ng/µl. Twelve individuals 
were chosen at random to act as replicates. Each DNA 
sample was split in two: half for preparation for 454 and 
the other half for preparation for MiSeq. The forward 
primer HNalla 5′-TCCCCACAGGTCTCCACAC-3′ 
and the reverse primer Rv3 5′-TGCGCTCCAGCTCCY 
TCTGCC-3′ were used to amplify a 236 to 242 bp long 
fragment of MHC class I exon 3 that contains the most 
variable portion of the peptide binding region [30, 33]. 
Although the use of a single primer pair may limit the 
number of alleles that are detected [42], for the current 
study the most important consideration was simply to 
have comparable data. In order to subsequently iden-
tify and separate the amplicons from each individual, 
the forward and reverse primers were each tagged with 
a unique 6 bp sequence combination [45] and either 454 
or MiSeq adaptor sequences. Separate polymerase chain 
reactions (PCRs) were performed on the samples for 454 
and MiSeq sequencing. PCRs were performed in 15-µl 
volumes containing QIAGEN Multiplex MasterMix, 
10–20  ng DNA and 0.2  µM of each primer (modified 
for either 454 or MiSeq). PCRs were performed using 
the following settings: 95 °C at 15 min, then 30 cycles of 
95 °C for 30 s, 65 °C for 60 s and 72 °C for 60 s, followed 
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by a final extension at 72  °C for 10  min. PCR products 
were verified on a 1.5% agarose gel stained with Syber 
Safe (Invitrogen). Amplified DNA from sets of eight indi-
viduals was pooled (separately for 454 and MiSeq i.e. 12 
pools per technique), in semi-equimolar volumes, and 
purified using a MinElute PCR purification kit (QIA-
GEN) according to the manufacturer’s instructions. The 
12 pools from each of the two sets of samples were then 
taken in equimolar volumes to form two separate final 
pools (i.e. one pool for 454 and one pool for MiSeq), 
that were then sent either for 250 bp paired-end illu-
mina MiSeq sequencing (illumina, Inc., San Diego, CA, 
USA) at the Sheffield Diagnostic Genetics Service or 454 
pyro-sequencing (Roche, Branford, CT, USA) at the DNA 
sequencing facility at the Department of Biology, Lund 
University. See Galan et  al. [24] and Kozich et  al. [45] 
for detailed descriptions of the 454 and MiSeq amplicon 
sequencing techniques, respectively. The 454 sequencing 
run was conducted in 2012, whereas the MiSeq sequenc-
ing run was conducted in 2013. In the case of the 454 
run, the 93 samples were in a single quadrant along with 
192 samples from another study. For the MiSeq run, the 
93 samples were in a single lane with 115 other samples. 
Prior experience of 454 sequencing of MHC-I in house 
sparrows [30] gave us confidence that the reads per sam-
ple, i.e. coverage, would be sufficient given 285 samples in 
the quadrant. For the MiSeq run, the number of reads per 
lane was anticipated to be so high that insufficient cover-
age given the number of samples was considered unlikely.
Sequence preprocessing
In the case of the MiSeq data, the sequences were assem-
bled, based on  ≥100  bp overlaps, using FLASH [46]. 
Next, PRINSEQ was used to remove any sequences with 
a Phred quality score below Q30 [47]. Finally, sequences 
were demultiplexed, trimmed of their tags and primer 
sequences, then summarised in a table listing the read 
number (read depth) of each sequence in each amplicon 
using jMHC [48]. In the case of the 454 data, the raw 
fasta file was processed by jMHC in the same manner.
Genotyping of MiSeq and 454‑data
Only variants between 239 and 242 bp in length (classical 
MHC class I genes) were retained in the dataset in order 
to eliminate variants of 236  bp in length (non-classical 
MHC class I genes) that were co-amplified [30, 42]. In the 
present study we will only focus on classical MHC class I 
alleles, which are characterized by high nucleotide diver-
sity and positively selected sites in exons 2 and 3 [30, 49, 
50].
The degree of change (DOC) method described by 
Lighten et  al. [17] was used for genotyping both MiSeq 
and 454 data as this is a widely used method in MHC 
studies [e.g. 18, 35, 36, 38, 51, 52]. This method uses the 
relative read depths of variants to distinguish true alleles 
from artefactual variants and enables an estimation of 
the number of alleles present in each individual (Ai). An 
important preliminary step in this method is to perform 
the initial error correction step as described by Lighten 
et  al. [17]. The error correction step increases the read 
depth of true alleles by assigning reads arising from arte-
facts to the true alleles from which they arose, i.e. the 
parent sequence. The parent sequence is a sequence with 
a high number of reads, considered a true allele. This 
‘cleaning’ step increases the read depth of true variants 
relative to artefactual variants, aiding the later calculation 
of the DOC value.
Error correction was performed separately and sequen-
tially on each amplicon. To identify variants arising from 
true alleles, the 50 variants with the highest read depths 
were aligned, separately for each amplicon, and neigh-
bour-joining trees produced in CodonCode aligner 5.0.2 
(CodonCode Corporation). These trees were used to 
visually assess the variants and identify possible artefacts 
as variants that differed from one another by just one or 
two nucleotides or containing homopolymers. The top 
50 variants were used as this should encompass the (up 
to) eight classical MHC alleles previously reported in 
house sparrow individuals [30, 40], though even higher 
numbers of classical MHC alleles cannot be excluded, as 
well as many common PCR or sequencing errors. This 
method relies upon an assumption that true alleles will 
have higher read numbers than variants arising from 
artefacts.
In the case of variants differing by one or two nucleo-
tides, the read depths of the two variants were compared. 
If one variant occurred at less than 50% of the read depth 
of the other variant then it was considered a possible 
artefact. In the case of the 454 data, we checked whether 
the same possible artefact occurred in any other ampli-
cons. If it only occurred in one amplicon it was consid-
ered an artefact and thus deleted and the read numbers 
added to the parent variant. If it occurred in more than 
one amplicon in the 454 dataset the variant was consid-
ered a true allele. A different rule was applied to vari-
ants differing by one or two nucleotides in the MiSeq 
data, as illumina sequencing is more prone to generating 
repeatable nucleotide substitution errors, i.e. miscalling 
the same nucleotide repeatedly depending on the flank-
ing nucleotide sequence [17, 53, 54]. Thus, in the MiSeq 
data a variant that differed from another by just one or 
two nucleotides was only considered to be a true allele if 
it always occurred at over 50% of the read depth of the 
other variant or was present in other amplicons without 
the putative parent variant. In the case of variants con-
taining homopolymers, which are particularly common 
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in 454 data, the variant was considered an artefact if it 
occurred at a lower read depth than the parent variant 
and did not occur in any other amplicon without the 
parent variant. As rare MHC alleles are expected within 
populations, variants occurring in a single sample were 
not discarded on this basis alone.
After error correction, the degree of change (DOC) 
value was calculated as detailed in Lighten et al. [17]. One 
of the key assumptions underpinning Lighten et al.’s [17] 
DOC method is that real alleles will be amplified at sig-
nificantly higher sequencing depths than artefacts. Thus, 
there should be a clear difference in the rate of change 
(ROC) in the cumulative sequencing depth between the 
true allele with the lowest sequencing depth and the 
artefact with the highest sequencing depth. Calculations 
described by Lighten et al. [17] enable the DOC around 
each variant to be calculated as a percentage of the total 
change among all variants, in their study using the top 
10 variants per individual on the assumption that up to 
eight true variants exist. In the current study the top 12 
variants were used to calculate the DOC, as up to eight 
true alleles were expected  [30, 40], but more were pos-
sible. Cumulative sequencing depth graphs were plotted 
in Microsoft Excel for each amplicon to enable the iden-
tification of genotypes with and without clear inflection 
points (Additional file  1: Figure  S1). Three people inde-
pendently evaluated each amplicon either as a ‘good 
amplicon’ with a clear inflection point or as a ‘poor 
amplicon’ without a clear inflection point; the latter were 
excluded from further analysis. The consensus require-
ment was that all three people should agree on whether 
an amplicon was ‘good’ or ‘poor’.
The mean read depths of true alleles (Ai, as calculated 
from the DOC method) and the mean read depths of 
artefacts were calculated per amplicon for different Ai 
values. The DOC method may exclude true alleles with 
poor amplification efficiency [16]. However, as such 
alleles would be excluded from both the 454 and MiSeq 
data, this does not influence comparability, which is the 
focus of the current study.
Quantitative comparison of MiSeq and 454
Quantitative comparisons of the performance of MiSeq 
and 454 were conducted by assessing the relative success 
rate (i.e. number of ‘good amplicons’) between the two 
methods. Additionally, the effect of different Ai values on 
the success rate was assessed both within and between 
the two techniques.
Qualitative comparison of MiSeq and 454
Qualitative comparisons of the performance of MiSeq 
and 454 were conducted by assessing the match between 
genotypes obtained within and between these two 
techniques. The proportion of genotypes that matched 
within the 12 replicated sample pairs was calculated, sepa-
rately for the MiSeq and 454 data, by dividing the number 
of replicate pairs that had matching genotypes by the total 
number of replicate pairs. The proportion of matching 
genotypes between the MiSeq and 454 data was assessed 
for the 81 individuals (i.e. replicates not included). This 
was calculated by dividing the number of matching geno-
types by the total number of possible genotype matches. 
The genotypes of the chicks were also compared to those 
of their parents, separately for the MiSeq and 454 data, to 
further verify the reliability of the genotypes.
Statistical analysis
Mann–Whitney U-tests were used to test whether there 
was a significant difference in the read depth between 
‘good’ and ‘poor’ amplicons for each technique [55]. A 
Fisher’s exact test was used to investigate whether the 
frequency of ‘good’ amplicons was similar between the 
two techniques [55].
Naming alleles
A BLAST query was performed on each allele remaining 
in the final dataset to check whether it had been previ-
ously identified. An allele was considered identical to a 
previously verified sequence only if it had 100% identity 
to the published sequence and was the same length. Iden-
tical alleles were given the same name as the published 
sequence. When alleles had 100% identity to a published 
sequence, but did not have 100% query coverage (i.e. they 
were shorter or longer than a published sequence but 
matched 100% in their overlapping segment), they were 
given the name of the published sequence followed by 
an ‘a’. The alleles that had not previously been reported 
were given species-specific names following the recom-
mended guidelines for naming new MHC alleles [56] and 
uploaded to GenBank.
Results
Sequencing depths before and after error correction
Considerably more reads were obtained from the MiSeq 
run than the 454 run: 727,913 reads in total for MiSeq 
and 17,687 in total for 454 (total number of reads for 
sequences with complete tags and primers). After 
removal of all singleton reads the mean (±se) number of 
reads per amplicon was 4923 ± 99 for MiSeq and 126 ± 3 
for 454. Once non-classical alleles were excluded the 
mean (±se) number of reads per amplicon was 2747 ± 58 
for MiSeq and 66  ±  1.6 for 454. Ninety-three and 92 
amplicons were successfully sequenced in the MiSeq and 
454 runs, respectively. For a summary of the mean read 
per amplicon at each stage of data processing, see Addi-
tional file 1: Table S1.
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After error correction, 24 and 17 ‘poor’ amplicons 
were discarded from the 454 and MiSeq datasets, respec-
tively (454: N = 68 remaining amplicons, MiSeq: N = 76 
remaining amplicons). After error correction and the 
removal of ‘poor’ amplicons, the mean (±se) number 
of reads per amplicon was 2818  ±  62 reads for MiSeq 
and 63 ±  2 for 454, i.e. MiSeq amplicons had a signifi-
cantly higher read depth. The mean (±se) number of 
reads per allele was 11 ±  0.3 (range: 3–36) for 454 and 
264 ± 7 (range: 65–768) for MiSeq. The total reads across 
all true alleles was 3711 for the 454 data and 96,924 for 
the MiSeq data. Thus 79% of the total reads were dis-
carded from the 454 data (13,976 out of 17,687) whereas 
87% were discarded from the MiSeq data (630,989 out of 
727,913). This high percentage of discarded reads in both 
datasets is largely attributable to the removal of non-clas-
sical alleles (Additional file 1: Table S1). The ‘poor’ ampli-
cons that were discarded from the dataset had lower read 
depths than the ‘good’ amplicons for both the MiSeq 
and the 454 data (Mann–Whitney U-test, ZMiSeq = 2.82, 
P < 0.005, Z454 = 2.87, P < 0.005; Table 1).
The same 21 MHC-I alleles were found in both the 454 
and MiSeq datasets (Additional file  1: Figure S2). 19 of 
these alleles have been previously found in other house 
sparrow individuals, supporting the validity of the geno-
typing protocol. We identified two new alleles (Pado-
UA*396 and Pado-UA*397, Genbank Accession Numbers 
KY314123 and KY314124). There were between three 
and nine putative alleles per individual whereas previous 
studies found up to eight alleles per individual [30, 40]. 
The higher number of alleles per individual in the current 
study either reflects copy number variation between indi-
viduals, which is a common feature of MHC genes [e.g. 
16, 17, 26, 57], or the relative heterozygosity/homozygo-
sity at different loci, which cannot be disentangled from 
these data. Furthermore, the same alleles may be shared 
among loci [see also 26], making it difficult to determine 
how many loci are present from the number of alleles per 
individual [57].
Separating alleles from artefacts in amplicons 
with different numbers of putative alleles
Overall, there was a clear difference in the cumula-
tive sequencing depth between true alleles and arte-
facts after error correction for both the MiSeq and 454 
data (Fig.  1). In the case of the MiSeq data, true alleles 
occurred at relative sequencing depths between 3.3 and 
19.1%, whereas artefacts were observed to have much 
lower depths, between 0.001 and 1.4% (Fig.  1a). In the 
454 data, the true alleles were observed at sequencing 
depths between 6.6 and 34.4%, whereas artefacts were 
observed at lower sequencing depths, between 0.05 and 
3.0% (Fig.  1b). These percentage values for MiSeq and 
454 were calculated based on the 50 variants with the 
highest sequencing depths and then presented as the 
proportion of the total reads in each amplicon in Fig. 1. 
In the case of the 454 data, the 50 variants represent a 
considerably higher proportion of the full dataset than 
in the MiSeq data because the raw 454 amplicons had an 
average of 106 variants whereas the raw MiSeq amplicons 
had an average of 4961 variants. Thus, the proportion of 
reads within the top 50 variants was higher for the 454 
data than the MiSeq data, although the number of reads 
was much higher for MiSeq as stated above. The differ-
ence between the cumulative sequencing depth of puta-
tive alleles and artefacts decreased as the number of 
alleles per amplicon increased in both the MiSeq and 454 
data.
Quantitative comparison of MiSeq and 454
Among the 81 and 80  amplicons in the MiSeq and 454 
data, respectively (replicates not included), there were 
more ‘good’ amplicons in the MiSeq data (69/81 i.e. 85%) 
than the 454 data (58/80 i.e. 73%). However, this differ-
ence was not statistically significant (Fisher’s exact test, 
P > 0.05).
For both the MiSeq and 454 data, the proportion of 
successfully genotyped amplicons was generally lower 
when the number of putative alleles was higher (Fig. 2). 
In amplicons with six or more alleles, a lower proportion 
of amplicons was successfully genotyped using 454 com-
pared to MiSeq.
Qualitative comparison of MiSeq and 454
Among the 12 replicated sample pairs, there were seven 
and two ‘good’ amplicon pairs for the MiSeq and 454 
data, respectively. There was 100% genotype match 
between the replicated amplicon pairs for both the MiSeq 
and 454 data.
Fifty-five individuals were successfully genotyped using 
both MiSeq and 454 (matching amplicons), with a mean 
genotype match of 98% across techniques. The 2% dis-
crepancy was the result of a mismatch between MiSeq 
and 454 genotyping in a single individual (MiSeq Ai = 6, 
454 Ai = 3). The number of true alleles in this individual 
Table 1 The number of  reads (after error correction) 
for  amplicons that  were classified as ‘good’ or ‘poor’ in  the 
MiSeq (‘good’, N  =  76 and  ‘poor’, N  =  17) and  454 data 
(‘good’, N = 68 and ‘poor’, N = 24)
Mean (±se) reads per amplicon
MiSeq 454
‘Good’ amplicons 2818 (62) 63 (2)
‘Poor’ amplicons 2427 (135) 53 (2)
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Fig. 1 Mean proportion of reads of the first 50 variants (true and artefact alleles) in amplicons with different numbers of putative true alleles (Ai) for 
the MiSeq (a) and the 454 (b) data. The mean sequencing depth for each allelic level (i.e. putative alleles ordered by depth) was calculated as the 
total number of reads from all successfully genotyped amplicons per allelic level divided by the total reads per amplicon. These calculations were 
performed separately on amplicons grouped by the number of putative alleles they possessed (Ai = 3 to 9 alleles). Total numbers of amplicons: 
NMiSeq = 76, N454 = 68. Grey bars show the sequencing depths of true alleles, whereas black bars show the sequencing depths of artefacts
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was likely to be six given that replicated samples in the 
MiSeq data both had six alleles whereas in the 454 data 
just one replicate was successfully genotyped.
Among the 11 families that were genotyped, seven and 
two families, in the MiSeq and 454 data, respectively, 
had enough ‘good’ amplicons to enable successful geno-
typing of both parents and one or more chicks. All the 
alleles detected in the chicks were found in at least one of 
the parents for both the MiSeq and 454 data (MiSeq, 41 
chicks; 454, 9 chicks).
Discussion
In this study we demonstrate similar performance 
between MiSeq and 454 amplicon sequencing for geno-
typing multi-locus MHC class I genes in a non-model 
species (house sparrows) with up to nine different alleles 
per individual. We first discuss the relative use and per-
formance of MiSeq and 454 for genotyping MHC in 
general. Next, we discuss the results of our quantitative 
and qualitative comparison of MiSeq and 454 to dis-
cover if, and at what complexity, MiSeq outcompetes 454. 
Finally, we briefly discuss methodological considerations 
for improving MHC genotyping using PCR and HTS 
techniques.
Since the introduction of 250 bp paired-end sequenc-
ing made MiSeq a viable option for MHC genotyping 
(around 2012), there has been a gradual increase in the 
number of studies using MiSeq for this purpose (Fig. 3). 
Roche began to phase out 454 in 2015, and although it 
still appears to be the dominant technology in recent 
publications, MiSeq will replace 454 over time. 454 has 
been repeatedly shown to offer a reliable alternative to 
more traditional, non-HTS, approaches for MHC geno-
typing in non-model species [15, 16, 58, 59]. However, we 
are not aware of many direct comparisons of MiSeq and 
454 for MHC genotyping. A recent study checked the 
congruence of MHC genotypes obtained using 454 and 
MiSeq in eight white-footed mice (Peromyscus leucopus), 
and found perfect agreement [60]. However, the individ-
uals in that study had just two MHC alleles each. Ours is 
the first study, to our knowledge, to compare directly the 
performance of these two HTS methods in a species with 
high MHC diversity.
In the current study, quantitative comparisons came 
from assessing the proportion of successful amplicons 
within and between each method, while qualitative com-
parisons came from assessing genotype matching. In 
terms of the quantitative comparisons, a slightly lower 
proportion of the 454 amplicons were considered ‘good 
amplicons’ and successfully genotyped (73%) than the 
MiSeq amplicons (85%). This difference between tech-
niques was more pronounced in amplicons with six or 
more alleles. Overall, the amplicons that were classified 
as ‘poor’ had significantly fewer reads in both the MiSeq 
and 454 data. This suggests that insufficient coverage led 
to these amplicons failing to be genotyped and, as pre-
viously stated, this was more common for the 454 data. 
However, as eight of the amplicons that were classified 
as ‘poor’ in both the 454 and MiSeq data came from the 
same individuals, it is likely that, in these cases, poor 
DNA quality prior to sequencing explains the failed 
genotyping.
In terms of the qualitative estimates, 454 and MiSeq 
were highly comparable. There was only a single case 
in which there was not a full genotypic match between 
the two methods (in an individual with Ai  =  6). Given 
the large discrepancy in the number of reads between 
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number of genotyped amplicons
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Fig. 3 The number of publications per year mentioning 454 or MiSeq 
from 2007 to 2016. Numbers obtained from Google Scholar using the 
search terms “major histocompatibility complex” and either “MiSeq 
sequencing” or “454 sequencing” on 18 May 2017
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these two methods (MiSeq: 2818  ±  62, 454: 63  ±  2, 
mean  ±  se), this is somewhat surprising and indicates 
that, although 454 provided fewer reads, they were of 
high quality. Indeed, the overall quality of reads in the 
current study may have been slightly higher for the 454 
run than the MiSeq run, given that a smaller percentage 
of the total reads were discarded from the 454 data com-
pared to the MiSeq data. Additionally, it should be noted 
that the reads per amplicon for the 454 data in this study 
were fairly low. Had we achieved greater read depth per 
amplicon in our 454 sequencing, it is very likely that the 
two methods (MiSeq and 454) would have been entirely 
equivalent in both their qualitative and quantitative 
performance.
The genotypes of chicks matched expectations, given 
the genotypes of their parents. In this study we used the 
family data to validate our genotyping protocol, but pedi-
gree information can also be a powerful tool to improve 
genotyping methods by enabling the identification of true 
alleles in poor quality amplicons [26].
Some of the methodological problems faced in HTS are 
PCR-based errors that occur before sequencing. When 
an error originates early in the PCR process an artefac-
tual variant can achieve a high read number in the final 
dataset, making it more difficult to discern from the true 
alleles. PCR-based problems can be minimized by opti-
mizing DNA extraction protocols [61] and by reducing 
the number of PCR cycles to 20–25 [62, 63], as artefact 
formation occurs at a higher rate with more cycles [62]. 
Another artefact that can occur prior to the HTS is cross-
contamination when setting up the PCR [64]. In our 
study, some amplicons included sequences that were sim-
ilar to putative alleles in other samples but were classified 
as artefacts due to low sequencing depth. These variants 
were most likely due to cross-contamination between 
DNA samples when setting up the PCR, a common 
occurrence in large multiplexing studies [17, 21]. As all 
21 MHC-I alleles in this study were detected in replicated 
amplicons from independent PCRs, we are confident that 
none of these alleles are the result of contamination.
We used the DOC protocol for genotyping MHC in 
this study. We found that this genotyping method accu-
rately separated putative alleles from artefacts in both 
the MiSeq and 454 data. The error correction stage of the 
DOC increases the read depth of true alleles by assigning 
some of the artefactual variants to their parent sequences, 
which facilitates accurate genotyping. Thus, it is possible 
that a more extensive error correction step could have 
enabled successful DOC genotyping in some of the ‘poor’ 
amplicons. Tools have recently become available [e.g. 65] 
that enable automated clustering of artefactual variants 
and true alleles, making more extensive error correction 
prior to performing DOC feasible. Another important 
methodological consideration for MHC genotyping is 
that of having sufficient coverage. As previously men-
tioned, genotyping failed in slightly more 454 samples 
than MiSeq samples, presumably due to insufficient cov-
erage. Although MiSeq offers increasingly high reads per 
sequencing run, it may still be important to consider the 
number of MHC alleles expected per sample and adjust 
the number of samples per run accordingly [15].
Conclusions
In conclusion, despite substantially lower reads in the 
454 data, there was high agreement between the HTS 
methods, MiSeq and 454, on genotyping classical MHC 
class I genes in house sparrows. Although more of the 
454 amplicons failed the genotyping procedure, of the 
55 amplicons that were genotyped successfully with both 
MiSeq and 454, the agreement was 98%, i.e. only a single 
sample failed. Our findings suggest that both MiSeq and 
454 are reliable techniques for assessing MHC genotypes 
when there is sufficient coverage, given the expected level 
of MHC diversity, and that the results obtained with the 
two methods are comparable (Additional files 2, 3).
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